Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 13.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 002187 | H. Przuntek ; D. Welzel [Allemagne] ; M. Gerlach ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; -J. Kaiser ; H. Kraus ; H. Letzel [Allemagne] ; P. Riederer ; K. Überla [Allemagne] | Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study |
| 002644 | H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne] | Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued |
| 002787 | K. Jellinger [Autriche] ; W. Paulus [Autriche] ; I. Grundke-Iqbal [États-Unis] ; P. Riederer [Allemagne] ; H. Youdim [Israël] | Brain iron and ferritin in Parkinson's and Alzheimer's diseases |
| 002877 | E. Sofic [Allemagne] ; P. Riederer [Allemagne] ; H. Heinsen [Allemagne] ; H. Beckmann [Allemagne] ; P. Reynolds [Royaume-Uni] ; G. Hebenstreit [Autriche] ; H. Youdim [Israël] | Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain |
| 002A13 | W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie] | Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study |
| 002A84 | P. Riederer [Autriche] ; K. Jellinger [Autriche] | Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline) |
| 002B81 | W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; M. B. H. Youdim [Israël] | Distinction between benign and malignant type of parkinson's disease |
| 002C33 | P. Riederer [Autriche] ; W. Birkmayer [Autriche] ; D. Seemann [Autriche] ; St. Wuketich [Autriche] | Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome |
| 002C41 | P. Riederer [Autriche] ; St. Wuketich [Autriche] | Time course of nigrostriatal degeneration in parkinson's disease |
| 002C56 | W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche] | The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil |
| 002C69 | W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings |
| 002C83 | W. Birkmayer [Autriche] ; W. Danielcyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | L-dopa level in plasma, primary condition for the kinetic effect |
| 002C95 | W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | The balance of biogenic amines as condition for normal behaviour |
| This area was generated with Dilib version V0.6.23. |  |